Pear Therapeutics

Pear Therapeutics, a pioneering digital therapeutics company, has filed for Chapter 11 bankruptcy and is terminating 170 employees, representing about 92% of its workforce. The Boston-based firm, which went public in 2021, will continue operating with a skeleton crew of 15 employees as it seeks a buyer for its assets. This drastic move follows the company's struggle to build a sustainable business model for its software-based treatments, having previously conducted layoffs and paused pipeline development in 2022 after failing to secure necessary funding.

Pear Therapeutics laid off 59 employees representing approximately 22% of its workforce on 2022-11-16.

Pear Therapeutics laid off 59 employees representing approximately 22% of its workforce on 2022-11-14.

Pear Therapeutics laid off 25 employees representing approximately 9% of its workforce on 2022-07-25.